Date updated:06-28-2008
One good thig about the selloff: Some stocks are now sporting much higher dividend yields. "You can structure a very well diversified portfolio" that also offers a nice yield, observes Ed Shill, chief investment officer of QCI Asset Management in Rochester, N.Y.

-
LGCY
Legacy Reserves L - $12.10
- +10.00%
- $11.32
Oil and gas limited partnerships are paying out notably high dividends. Legacy Reserves (ticker: LGCY), which yields 8.2%, and Atlas Energy Resources (ATN), which yields 6.3%, are two favorites of Wayne Nordberg, chairman of investment manager Hollow Brook Associates. "They're smaller, well positioned and are in the early stage of development," he says.

-
ATN
Atlas Energy Reso - $16.20
- +7.86%
- $15.11
Oil and gas limited partnerships are paying out notably high dividends. Legacy Reserves (ticker: LGCY), which yields 8.2%, and Atlas Energy Resources (ATN), which yields 6.3%, are two favorites of Wayne Nordberg, chairman of investment manager Hollow Brook Associates. "They're smaller, well positioned and are in the early stage of development," he says.

-
CZN
Czn - $0.00
- N/A
- $N/A
Some of the small regional telephone companies might not be glamorous, but they're generating nice cash flows. Citizen Communications (CZN) offers investors an 8.9% yield while Qwest Communications (Q) has a 7.9% yield. Of course, competition from cable companies and wireless providers is the threat that can't be ignored in this sector.

-
Q
Qwest Comm Intl I - $3.61
- +3.74%
- $3.55
Some of the small regional telephone companies might not be glamorous, but they're generating nice cash flows. Citizen Communications (CZN) offers investors an 8.9% yield while Qwest Communications (Q) has a 7.9% yield. Of course, competition from cable companies and wireless providers is the threat that can't be ignored in this sector.

-
PFE
Pfizer Inc - $17.80
- -1.98%
- $18.32
Everyone hates the drug companies, because their drugs have lost patent protection and few new offerings have filled the void. But some still throw off good cash flow, and buying them is a bet that their research crews will eventually hit gold. Among the highest yields: Pfizer (PFE), at 7.2%, and Bristol-Myers Squibb (BMY), at 6.1%.

-
BMY
Bristol Myers Sqi - $22.35
- -3.79%
- $23.37
Everyone hates the drug companies, because their drugs have lost patent protection and few new offerings have filled the void. But some still throw off good cash flow, and buying them is a bet that their research crews will eventually hit gold. Among the highest yields: Pfizer (PFE), at 7.2%, and Bristol-Myers Squibb (BMY), at 6.1%.

-
NLY
Annaly Capital Ma - $15.95
- +3.98%
- $15.50
Annaly does have leverage of 8-to-1, so if Wall Street decides not to lend to it anymore, the company will run into problems. (Carlyle's leverage was north of 30-to-1.) Likewise, if short-term interest rates rise and long-term rates fall, the company's income will fall and the dividend will get cut. But given the current economic environment, Annaly's 13.9% dividend yield is a good bet.
- Top Professional Portfolios
- 1. Charlie Munger
- 2. Bernard L. Madoff Inve...
- 3. Renaissance Technologies
- 4. Templeton World A (TEMWX)
- 5. Fidelity Select Consum...
- show all
- Top Do-It-Yourself Portfolios
- » Joy
- » tsamanuli Portfolio 1
- » brueckenc Portfolio 1
- » HMH1
- » Fundsonly Portfolio 1
- show all
- Most Viewed Portfolios
- » Warren Buffett
- » 10 Short Squeezes
- » George Soros
- » T. Boone Pickens - BP Cap...
- » Carl Icahn
- show all
Investors were spooked on Wednesday as bleak broad-based corporate outlooks and dismal employment data dominated headlines. Stocks experienced their largest drop in more t...
At Stockpickr.com, we strive to keep track of insider purchasing and buybacks each week. Here's the perfect setup in my mind: insiders buying the stock, the company buying ...
The traders of CNBC’s "Fast Money" think the current stock market is a traders' market. In order to play a traders' market, you have to nimble. You also have to know whic...
Pfizer (PFE) CEO Jeff Kindler has hinted that the world’s biggest drugmaker is open to a large-scale acquisition. “The real goal is to grow revenues," he told the Fina...
A. do yourself a big favor and read cramers
books first. no one should be in the
market without some knowledge of how it
works. also, the market may well be over
valued. no one knows. finally, if you
just have to ignore this advice, stay
way away from 2x or 3x etf's. good luck,
mike
A. small trading before thrusday
Analyst Upgrades for Jan. 5, 2009 more
This list consists of stocks that have had very nice up move over the last year and may be poised to disappoint going forward. The basis for the list is as follows: 52 w... more
This portfolio consists of NYSE stocks that are trading for less than $5 per share and are profitable. more






Comments not available